The cost-effectiveness of targeted screening for congenital cytomegalovirus in newborns compared to clinical diagnosis in the US
Victoria Phillips, Junjun Xu, Albert Park, Soren Gantt, Kavita Dedhia
Topics & Concepts
MedicineReimbursementPediatricsNewborn screeningCost effectivenessCytomegalovirusHealth careFamily medicineHuman immunodeficiency virus (HIV)EconomicsRisk analysis (engineering)Viral diseaseEconomic growthHerpesviridaeCytomegalovirus and herpesvirus researchImmunodeficiency and Autoimmune DisordersNeonatal Health and Biochemistry